https://orcid.org/0000-0001-5058-3484
Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sugan Panneerselvam, Cornelia Wilson, Prem Kumar, Dinu Abirami, Jayakrishna Pamarthi, Mettu Srinivas Reddy & Joy Varghese. (2023) Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. Cell Adhesion & Migration 17:1, pages 1-21.
Read now
Read now
Baitul Islam, Hai-Yang Yu, Tian-Qi Duan, Jing Pan, Min Li, Ru-Qi Zhang, Matiullah Masroor & Ju-Fang Huang. (2023) Cell cycle kinases (AUKA, CDK1, PLK1) are prognostic biomarkers and correlated with tumor-infiltrating leukocytes in HBV related HCC. Journal of Biomolecular Structure and Dynamics 41:21, pages 11845-11861.
Read now
Read now
Articles from other publishers (37)
Yingming Fei, Zhiwei Wang, Minmin Huang, Xinjuan Wu, Fangqin Hu, Jinlong Zhu, Youlin Yu, Huajiang Shen, Yong Wu, Guilin Xie & Zumo Zhou. (2023)
MiR
‐155 regulates
M2
polarization of hepatitis B virus‐infected tumour‐associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma
. Journal of Viral Hepatitis 30:5, pages 417-426.
Crossref
Crossref
Yi Gong, Qing Peng, Yuting Gao, Jiali Yang, Junlan Lu, Yuman Zhang, Yanguang Yang, Hua Liang, Yuan Yue & Xinli Shi. (2023) Dihydroartemisinin inhibited interleukin-18 expression by decreasing YAP1 in hepatocellular carcinoma cells. Acta Histochemica 125:4, pages 152040.
Crossref
Crossref
Xu-Jia Shi, Chen-Guang Yao, Han-Luo Li, Yan-Hong Wei & Kang-Hong Hu. (2023) Chromosome hyperploidy induced by chronic hepatitis B virus infection and its targeted therapeutic strategy. World Chinese Journal of Digestology 31:8, pages 299-306.
Crossref
Crossref
Riccardo Nevola, Domenico Beccia, Valerio Rosato, Rachele Ruocco, Davide Mastrocinque, Angela Villani, Pasquale Perillo, Simona Imbriani, Augusto Delle Femine, Livio Criscuolo, Maria Alfano, Marco La Montagna, Antonio Russo, Raffaele Marfella, Domenico Cozzolino, Ferdinando Carlo Sasso, Luca Rinaldi, Aldo Marrone, Luigi Elio Adinolfi & Ernesto Claar. (2023) HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis. International Journal of Molecular Sciences 24:8, pages 7651.
Crossref
Crossref
Hongjuan You, Ning Zhang, Tong Yu, Lihong Ma, Qi Li, Xing Wang, Dongchen Yuan, Delong Kong, Xiangye Liu, Wei Hu, Dongsheng Liu, Fanyun Kong, Kuiyang Zheng & Renxian Tang. (2023) Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis. British Journal of Cancer 128:6, pages 992-1004.
Crossref
Crossref
Kiyasha Padarath, Aurélie Deroubaix & Anna Kramvis. (2023) The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma. Viruses 15:4, pages 857.
Crossref
Crossref
Fabio Sandomenico, Valerio Arpaia, Ferdinando De Rosa, Orlando Catalano, Roberto Antonino Buonaiuto, Marianna Notarangelo, Maria Iovino, Sabrina Giovine, Arturo Brunetti & Mariano Scaglione. (2023) Spontaneously Ruptured Hepatocellular Carcinoma: Computed Tomography-Based Assessment. Diagnostics 13:6, pages 1021.
Crossref
Crossref
Jinglin Wang, Senzhe Xia, Yuyan Chen, Xueqian Qin, Shujun Liu & Haozhen Ren. (2023) Screening and validation of prognostic indicator genes in the progression of HBV related hepatocellular carcinoma. Biomedical Technology 1, pages 10-17.
Crossref
Crossref
Lili He, Huanyu Shen, Hui Deng, Xiaoyan Zhang, Yang Xu, Chunwei Shi & Zhuqing Ouyang. (2023) Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus production. Antiviral Research 211, pages 105519.
Crossref
Crossref
Riccardo Nevola, Rachele Ruocco, Livio Criscuolo, Angela Villani, Maria Alfano, Domenico Beccia, Simona Imbriani, Ernesto Claar, Domenico Cozzolino, Ferdinando Carlo Sasso, Aldo Marrone, Luigi Elio Adinolfi & Luca Rinaldi. (2023) Predictors of early and late hepatocellular carcinoma recurrence. World Journal of Gastroenterology 29:8, pages 1243-1260.
Crossref
Crossref
Mariantonietta Di Stefano, Giuseppina Faleo, Thomas Leitner, Wei Zheng, Yang Zhang, Amna Hassan, Marwan J. Alwazzeh, Josè R. Fiore, Mona Ismail & Teresa A. Santantonio. (2023) Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals. Viruses 15:2, pages 458.
Crossref
Crossref
Xiaoqing Zhong, Zhenning Di, Yuanxin Xu, Qifan Liang, Kuanhan Feng, Yuting Zhang, Liuqing Di & Ruoning Wang. (2022) Mineral medicine: from traditional drugs to multifunctional delivery systems. Chinese Medicine 17:1.
Crossref
Crossref
Shreyas H. Karunakara, Lakshana D. Puttahanumantharayappa, Nirmala G. Sannappa Gowda, Varsha D. Shiragannavar & Prasanna K. Santhekadur. (2022) Novel Insights into MEG3/miR664a-3p/ADH4 Axis and Its Possible Role in Hepatocellular Carcinoma from an in Silico Perspective. Genes 13:12, pages 2254.
Crossref
Crossref
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Chidi V Nnabuchi, Ponsiano Ocama, Edith Okeke, John Rwegasha, Abate B Shewaye, Fatuma F Some, Christian Tzeuton & Mark W Sonderup. (2022) Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 7:11, pages 1036-1048.
Crossref
Crossref
Guojun Hou, Dongyang Ding, Tao Tian, Wei Dong, Dapeng Sun, Gang Liu, Yuan Yang & Weiping Zhou. (2022) Metabolomics‐based classification reveals subtypes of hepatocellular carcinoma. Molecular Carcinogenesis 61:11, pages 989-1001.
Crossref
Crossref
Elias Kouroumalis, Ioannis Tsomidis & Argryro Voumvouraki. (2022) Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?. Livers 2:4, pages 315-335.
Crossref
Crossref
Man Li, Hongzhen Cai, Ruiyi Deng, Jin Cheng & Yanyan Shi. (2022) Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review). International Journal of Oncology 61:6.
Crossref
Crossref
Qin Yu, Zhe Chen, Minglin Liu, Yongbin Meng, Xiaoyan Li, Bai Li & Juan Du. (2022) Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology. Journal of Ethnopharmacology 297, pages 115531.
Crossref
Crossref
Chou Yang, Haitao Chen, Bin Zhou, Jianhua Yin, Guangwen Cao, Jinlin Hou & Deke Jiang. (2022)
The effects of the interactions of
STAT4
rs7574865 with HBV mutations on the risk of hepatocellular carcinoma
. Molecular Carcinogenesis 61:10, pages 933-940.
Crossref
Crossref
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas & Urania Georgopoulou. (2022) Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. International Journal of Molecular Sciences 23:18, pages 10862.
Crossref
Crossref
Fei Xu, Qingkang Meng, Feng Wu, Yakun Wang, Wenjun Yang, Yun Tong, Lei Liu & Xiujie Chen. (2022) Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC. Oxidative Medicine and Cellular Longevity 2022, pages 1-29.
Crossref
Crossref
Hongbo Wang, Fang Chu, Li Zhijie, Qian Bi, Li Lixin, Yunlong Zhuang, Zhang Xiaofeng, Xiaofeng Niu, Dali Zhang, He Xi & Bo-an Li. (2022) MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells. Frontiers in Oncology 12.
Crossref
Crossref
Yan Gao, Yan Li, Ziyan Song, Zhenxing Jin, Xiao Li & Chunluan Yuan. (2022) Sortilin 1 Promotes Hepatocellular Carcinoma Cell Proliferation and Migration by Regulating Immune Cell Infiltration. Journal of Oncology 2022, pages 1-13.
Crossref
Crossref
Wei Hu, Dongsheng Liu, Renjie Li, Hong Qian, Wei Qiu, Qingwang Ye & Fanyun Kong. (2022) Comprehensive Analysis of TRIM Family Genes in Hepatitis Virus B-Related Hepatoma Carcinoma. Frontiers in Genetics 13.
Crossref
Crossref
Fengxia Du, Huiwei Sun, Fang Sun, Shiwei Yang, Haidong Tan, Xiaojuan Li, Yantao Chai, Qiyu Jiang & Dongdong Han. (2022) Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs. Frontiers in Pharmacology 13.
Crossref
Crossref
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo & Antonio Craxì. (2022) Hepatitis B Virus-Associated Hepatocellular Carcinoma. Viruses 14:5, pages 986.
Crossref
Crossref
A. D. Nikogosova, D. V. Umrik & O. M. Tsirulnikova. (2022) Post-liver transplant HBV infection (Review). Russian Journal of Transplantology and Artificial Organs 24:2, pages 31-38.
Crossref
Crossref
Nguyen Thi Cam Huong, Nguyen Quang Trung, Bac An Luong, Duong Bich Tram, Hoang Anh Vu, Hoang Huu Bui & Hoa Pham Thi Le. (2022) Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients. PLOS ONE 17:4, pages e0266134.
Crossref
Crossref
Qiao Zhou, Qi Zhang, Kaiwen Wang, Ting Huang, Shaoping Deng, Yi Wang & Chunming Cheng. (2022) Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma. Pharmacological Research 178, pages 106181.
Crossref
Crossref
Yannick Tréguier, Anne Bull-Maurer & Philippe Roingeard. (2022) Apolipoprotein E, a Crucial Cellular Protein in the Lifecycle of Hepatitis Viruses. International Journal of Molecular Sciences 23:7, pages 3676.
Crossref
Crossref
Hongjuan You, Suping Qin, Fulong Zhang, Wei Hu, Xiaocui Li, Dongsheng Liu, Fanyun Kong, Xiucheng Pan, Kuiyang Zheng & Renxian Tang. (2022) Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection. Frontiers in Immunology 13.
Crossref
Crossref
Dariusz Zakrzewicz & Joachim Geyer. (2022) Multitasking Na+/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery. Biomedicines 10:1, pages 196.
Crossref
Crossref
文雯 许. (2022) The Role of TRAF7 in Tumorigenesis. World Journal of Cancer Research 12:03, pages 188-198.
Crossref
Crossref
Akanksha Suresh & Renumathy Dhanasekaran. 2022. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Hepatobiliary Cancers: Translational Advances and Molecular Medicine
103
135
.
Po-Shuan Huang, Chia-Jung Liao, Ya-Hui Huang, Chau-Ting Yeh, Cheng-Yi Chen, Hui-Chi Tang, Cheng-Chih Chang & Kwang-Huei Lin. (2021) Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers 13:21, pages 5361.
Crossref
Crossref
Dawei Cui, Wei Li, Daixi Jiang, Jianguo Wu, Jue Xie & Yingping Wu. (2021) Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma. Frontiers in Medicine 8.
Crossref
Crossref
Yung-Tsung Li, Hui-Lin Wu & Chun-Jen Liu. (2021) Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1. International Journal of Molecular Sciences 22:17, pages 9380.
Crossref
Crossref